ARKG
- ARK Genomic Revolution ETFInformazioni chiave
| Data più antica | 2014-10-31 |
Informazioni ETF
| Emittente del fondo | ARK Invest |
| Indice | Active (No Index) |
| Commissione di gestione | 0.75% |
| Numero di titoli in portafoglio | 42 |
| Data di lancio | 2014-10-31 |
| Classe di asset | Equity |
| Quotazione | US-listed |
| Settore | Healthcare |
| Stile di investimento | Growth |
| Senza leva finanziaria | Non-leveraged |
Informazioni su ARKG
The ARK Genomic Revolution ETF is an actively managed fund that invests in companies driving advancements in genomics, gene editing, genetic therapy, molecular diagnostics, and stem cell advances. The fund's portfolio is tilted towards smaller firms and is designed to capture long-term growth potential in the healthcare and biotechnology sectors.